Thermo Fisher Scientific, Inc. (TMO)
694.76
+17.82
(+2.63%)
USD |
NYSE |
Nov 06, 16:00
695.70
+0.94
(+0.13%)
Pre-Market: 20:00
Thermo Fisher Scientific Cash from Investing (Quarterly) : -77.00M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -77.00M |
| June 30, 2026 | 164.00M |
| March 31, 2026 | -8.961B |
| December 31, 2025 | 891.00M |
| September 30, 2025 | -4.123B |
| June 30, 2025 | -288.00M |
| March 31, 2025 | -527.00M |
| December 31, 2024 | 20.00M |
| September 30, 2024 | -3.578B |
| June 30, 2024 | -253.00M |
| March 31, 2024 | -2.03B |
| December 31, 2023 | -376.00M |
| September 30, 2023 | -1.181B |
| June 30, 2023 | -443.00M |
| March 31, 2023 | -3.142B |
| December 31, 2022 | -525.00M |
| September 30, 2022 | -545.00M |
| June 30, 2022 | -419.00M |
| March 31, 2022 | -670.00M |
| December 31, 2021 | -18.69B |
| September 30, 2021 | -616.00M |
| June 30, 2021 | -626.00M |
| March 31, 2021 | -1.998B |
| December 31, 2020 | -626.00M |
| September 30, 2020 | -365.00M |
| Date | Value |
|---|---|
| June 30, 2020 | -259.00M |
| March 31, 2020 | -260.00M |
| December 31, 2019 | -339.00M |
| September 30, 2019 | -198.00M |
| June 30, 2019 | -769.00M |
| March 31, 2019 | -181.00M |
| December 31, 2018 | -721.00M |
| September 30, 2018 | -168.00M |
| June 30, 2018 | -185.00M |
| March 31, 2018 | -179.00M |
| December 31, 2017 | -283.00M |
| September 30, 2017 | -6.969B |
| June 30, 2017 | -95.10M |
| March 31, 2017 | -381.90M |
| December 31, 2016 | -88.10M |
| September 30, 2016 | -4.196B |
| June 30, 2016 | -108.70M |
| March 31, 2016 | -1.139B |
| December 31, 2015 | -511.40M |
| September 30, 2015 | -106.70M |
| June 30, 2015 | -75.00M |
| March 31, 2015 | -394.30M |
| December 31, 2014 | -126.00M |
| September 30, 2014 | 417.40M |
| June 30, 2014 | -6.20M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Agilent Technologies, Inc. | -1.032B |
| Danaher Corp. | -300.00M |
| Illumina, Inc. | 50.00M |
| Bio-Rad Laboratories, Inc. | -- |
| Revvity, Inc. | -15.60M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 2.55B |
| Cash from Financing (Quarterly) | -1.063B |
| Free Cash Flow | 7.596B |
| Free Cash Flow Per Share (Quarterly) | 5.695 |
| Free Cash Flow to Equity (Quarterly) | 3.292B |
| Free Cash Flow to Firm (Quarterly) | 2.545B |
| Free Cash Flow Yield | 2.93% |